| | Business Summary | | Endocare,
Inc.
is
a
vertically
integrated
medical
device
company
that
develops,
manufactures
and
markets
cryosurgical
and
stent
technologies
for
applications
in
oncology
and
urology.
The
Company
has
concentrated
on
developing
devices
for
the
treatment
of
two
common
diseases
of
the
prostate,
prostate
cancer
and
benign
prostate
hyperplasia
(BPH).
The
Company
is
also
developing
cryosurgical
technologies
for
treating
tumors
in
other
organs,
including
the
kidney,
breast
and
liver.
Endocare
has
developed
products
that
include
the
Cryocare-4
Probe
system,
Cryocare-8
Probe
System,
FastTrac,
CryoGuide
and
Horizon
Prostatic
Stent.
The
Company
has
developed
the
Cryocare
System,
a
next-generation
cryosurgery
system,
to
allow
the
urologist
to
treat
prostate
cancer
in
a
minimally
invasive
manner.
The
Company
has
also
developed
a
new
urological
stent
that
has
been
designed
to
provide
immediate
relief
for
BPH
patients
who
undergo
thermotherapy,
called
the
Horizon
Prostatic
Stent. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Endocare,
Inc.
develops,
manufactures
and
markets
an
array
of
temperature-based
surgical
devices
and
technologies
to
treat
prostate
disease,
including
prostate
cancer
and
prostate
enlargement.
For
the
six
months
ended
6/30/01,
revenues
totaled
$6.3
million,
up
from
$2.9
million.
Net
loss
decreased
31%
to
$4.4
million.
Results
reflect
increased
system
sales
and
sales
of
cryosurgical
disposables,
improved
profit
margins,
and
$38
thousand
in
net
interest
income
vs.
a
net
expense
in
2000. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Paul Mikus, 35
Chairman,
Pres, CEO | $289K | John Cracchiolo
CFO,
Chief Operating Officer | -- | Kevin Quilty
Sr. VP of Sales and Marketing | -- | Vincent Cutarelli, 50
Sr.
VP- Regulatory Affairs/Quality Assurance | 213K | Holly Williams
VP
of HR, Gen. Counsel | -- | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/e/endo.gif)